m6A modification of LINC00458 enhances HMOX1 stability via ELAVL1 recruitment to promote ferroptosis and aggravate asthma
Molecular Immunology · 2026-08 · 196 · 186-197
DOI: 10.1016/j.molimm.2026.06.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Immunology, 2026-08. Verfasst von Xiaoying Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric department, The First Affiliated Hospital of Guangzhou Medical University, No. 151, Yanjiang West Road, Yuexiu District 510120, Guangzhou, …. Hauptthemen laut MEDLINE: ELAV-Like Protein 1, Asthma, Heme Oxygenase-1, Ferroptosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Asthma is a chronic inflammatory disease of the airways, characterized by immune cell infiltration and airway hyperresponsiveness. Recent studies have identified lncRNAs as key regulators in asthma pathogenesis, but the underlying mechanisms remain unclear. LINC00458, a lncRNA, has been implicated in various diseases, yet its role in asthma has not been thoroughly investigated. AIM: This study aims to explore the role of LINC00458 in asthma and its potential mechanism in regulating inflammation and ferroptosis. METHODS: The expression of LINC00458 in asthma cells and tissues was measured using qPCR. The effects of LINC00458 knockdown were evaluated in primary human bronchial epithelial (NHBE) cells treated with house dust mite (HDM) extract. The interaction between LINC00458 and ELAVL1 was assessed using RNA pulldown and RIP-qPCR. HMOX1 mRNA stability and its impact on ferroptosis were also analyzed. Finally, the m6A modification of LINC00458 was examined using MeRIP-qPCR and RNA pulldown assays. RESULTS: LINC00458 was upregulated in asthma cells and tissues. Knockdown of LINC00458 suppressed ferroptosis and inflammatory cytokine release. LINC00458 stabilized HMOX1 mRNA by interacting with the RNA-binding protein ELAVL1. Furthermore, METTL3-mediated m6A modification promoted the stability of LINC00458, enhancing its inflammatory response regulation. CONCLUSION: LINC00458 plays a significant role in asthma by modulating inflammation and ferroptosis. Its interaction with ELAVL1 and m6A modification pathway suggests potential therapeutic targets for asthma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric department, The First Affiliated Hospital of Guangzhou Medical University, No. 151, Yanjiang West Road, Yuexiu District 510120, Guangzhou, Guangdong, China.
- Pediatric department, The First Affiliated Hospital of Guangzhou Medical University, No. 151, Yanjiang West Road, Yuexiu District 510120, Guangzhou, Guangdong, China. Electronic address: 13929578231@163.com.
Zitieren
APA
Yu, X., Chen, L., Liang, J., He, Z., Xu, J., Huang, Z., Liang, H., Lu, C., & Zhai, Y. (2026). m6A modification of LINC00458 enhances HMOX1 stability via ELAVL1 recruitment to promote ferroptosis and aggravate asthma. Molecular Immunology, 196, 186-197. https://doi.org/10.1016/j.molimm.2026.06.003
Vancouver
Yu X, Chen L, Liang J, He Z, Xu J, Huang Z, et al. m6A modification of LINC00458 enhances HMOX1 stability via ELAVL1 recruitment to promote ferroptosis and aggravate asthma. Molecular Immunology. 2026;196:186-197. doi:10.1016/j.molimm.2026.06.003
BibTeX
@article{Yu2026,
author = {Yu, Xiaoying and Chen, Liwen and Liang, Jinglian and He, Zhentao and Xu, Jiaxing and Huang, Zhanhang and Liang, Huanxin and Lu, Chengyu and Zhai, Yingying},
title = {m6A modification of LINC00458 enhances HMOX1 stability via ELAVL1 recruitment to promote ferroptosis and aggravate asthma},
journal = {Molecular Immunology},
year = {2026},
volume = {196},
pages = {186--197},
doi = {10.1016/j.molimm.2026.06.003}
}
EUVIMED